Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  59 results for ""Respiratory Syncytial Virus, Human""

Your Filters

Publication : frontiers in immunology Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Experimental trials of predicted CD4 + and CD8 + T-cell epitopes of respiratory syncytial virus.

  • Authors : Qousain Naqvi ST; Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan, Pakistan.; Muhammad SA

Subjects: Epitopes, T-Lymphocyte*/Epitopes, T-Lymphocyte*/Epitopes, T-Lymphocyte*/metabolism ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/immunology ; Respiratory Syncytial Virus, Human*/Respiratory Syncytial Virus, Human*/Respiratory Syncytial Virus, Human*/metabolism

  • Source: Frontiers in immunology [Front Immunol] 2024 Apr 02; Vol. 15, pp. 1349749. Date of Electronic Publication: 2024 Apr 02 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Cooperative interaction of interferon regulatory factor -1 and bromodomain-containing protein 4 on RNA polymerase activation for intrinsic innate immunity.

  • Authors : Xu X; Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health (SMPH), Madison, WI, United States.; Qiao D

Subjects: Immunity, Innate* ; Respiratory Syncytial Virus Infections* ; Respiratory Syncytial Virus, Human*

  • Source: Frontiers in immunology [Front Immunol] 2024 Mar 27; Vol. 15, pp. 1366235. Date of Electronic Publication: 2024 Mar 27 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Determinants of immunoglobulin G responses to respiratory syncytial virus and rhinovirus in children and adults.

  • Authors : Guillien A; University Grenoble Alpes, Inserm U 1209, CNRS UMR 5309, Team in Environmental Epidemiology Applied to Development and Respiratory Health, Institute for Advanced Biosciences, Grenoble, France.; Niespodziana K

Subjects: Respiratory Syncytial Virus Infections* ; Respiratory Syncytial Virus, Human* ; Viruses*

  • Source: Frontiers in immunology [Front Immunol] 2024 Mar 04; Vol. 15, pp. 1355214. Date of Electronic Publication: 2024 Mar 04 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Bacterial small RNAs may mediate immune response differences seen in respiratory syncytial virus versus rhinovirus bronchiolitis.

  • Authors : Krohmaly KI; Integrated Biomedical Sciences, The George Washington University, Washington, DC, United States.; Center for Genetic Medicine Research, Children's National Research and Innovation Center, Washington, DC, United States.

Subjects: Bronchiolitis*/Bronchiolitis*/Bronchiolitis*/genetics ; Respiratory Syncytial Virus, Human*/Respiratory Syncytial Virus, Human*/Respiratory Syncytial Virus, Human*/genetics ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/genetics

  • Source: Frontiers in immunology [Front Immunol] 2024 Feb 12; Vol. 15, pp. 1330991. Date of Electronic Publication: 2024 Feb 12 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Clinical research on RSV prevention in children and pregnant women: progress and perspectives.

  • Authors : Gong X; Good Clinical Practice Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.; Luo E

Subjects: Respiratory Syncytial Virus Infections* ; Respiratory Syncytial Virus, Human* ; Respiratory Syncytial Virus Vaccines*

  • Source: Frontiers in immunology [Front Immunol] 2024 Jan 24; Vol. 14, pp. 1329426. Date of Electronic Publication: 2024 Jan 24 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Non-glycosylated G protein with CpG ODN provides robust protection against respiratory syncytial virus without inducing eosinophilia.

  • Authors : Kawahara E; Laboratory of Nano-design for Innovative Drug Development, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.; Vaccine Creation Group, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Subjects: Respiratory Syncytial Virus Infections* ; Respiratory Syncytial Virus, Human* ; Pneumonia*

  • Source: Frontiers in immunology [Front Immunol] 2023 Dec 19; Vol. 14, pp. 1282016. Date of Electronic Publication: 2023 Dec 19 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults.

Subjects: Respiratory Syncytial Virus Infections* ; Respiratory Syncytial Virus, Human*; Humans

  • Source: Frontiers in immunology [Front Immunol] 2023 Oct 13; Vol. 14, pp. 1260146. Date of Electronic Publication: 2023 Oct 13 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Fc-mediated functions of nirsevimab complement direct respiratory syncytial virus neutralization but are not required for optimal prophylactic protection.

  • Authors : Brady T; Translational Medicine, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.; Cayatte C

Subjects: Respiratory Syncytial Virus, Human* ; Respiratory Syncytial Virus Infections*; Infant

  • Source: Frontiers in immunology [Front Immunol] 2023 Oct 11; Vol. 14, pp. 1283120. Date of Electronic Publication: 2023 Oct 11 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Report

Case Report: ASCENIV use in three young children with immune abnormalities and acute respiratory failure secondary to RSV infection.

  • Authors : Bindernagel C; Department of Pediatrics, Division of Allergy and Immunology, University of South Florida Morsani College of Medicine, Tampa, FL, United States.; Department of Allergy and Immunology, Johns Hopkins All Children's Hospital, Saint Petersburg, FL, United States.

Subjects: Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/complications ; Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/Respiratory Syncytial Virus Infections*/drug therapy ; Respiratory Syncytial Virus, Human*

  • Source: Frontiers in immunology [Front Immunol] 2023 Sep 14; Vol. 14, pp. 1154448. Date of Electronic Publication: 2023 Sep 14 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Exacerbated lung inflammation following secondary RSV exposure is CD4+ T cell-dependent and is not mitigated in infant BALB/c mice born to PreF-vaccinated dams.

  • Authors : Kosanovich JL; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States.; Eichinger KM

Subjects: Respiratory Syncytial Virus, Human* ; Pneumonia*/Pneumonia*/Pneumonia*/prevention & control ; Asthma*

  • Source: Frontiers in immunology [Front Immunol] 2023 Aug 14; Vol. 14, pp. 1206026. Date of Electronic Publication: 2023 Aug 14 (Print Publication: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  59 results for ""Respiratory Syncytial Virus, Human""